Odonate Therapeutics, Inc. Increase (Decrease) in Deferred Liabilities
Odonate Therapeutics, Inc. reported Increase (Decrease) in Deferred Liabilities of $433.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-02-20.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredLiabilities · last filed 2020-02-20
- Odonate Therapeutics, Inc. increase (decrease) in deferred liabilities for the quarter ending 2018-12-31 was $1.00K.
- Odonate Therapeutics, Inc. increase (decrease) in deferred liabilities for the quarter ending 2018-09-30 was -$1.00K.
- Odonate Therapeutics, Inc. increase (decrease) in deferred liabilities for fiscal 2018 was $433.00K.
| Period end | Increase (Decrease) in Deferred Liabilities 3 month | Increase (Decrease) in Deferred Liabilities 6 month | Increase (Decrease) in Deferred Liabilities 9 month | Increase (Decrease) in Deferred Liabilities 12 month |
|---|---|---|---|---|
| 2018-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $0.00 derived: sum of 2 quarters · filed 2020-02-20 | $433.00K 10-K · filed 2020-02-20 | |
| 2018-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $432.00K 10-Q · filed 2019-11-06 | ||
| 2018-06-30 | $433.00K 10-Q · filed 2019-07-24 |